Home    Back

Ta-650    (DrugBank: -)

4 diseases
IDDisease name (Link within this page)Number of trials
37Generalised pustular psoriasis1
56Behcet disease1
96Crohn disease2
97Ulcerative colitis2

37. Generalised pustular psoriasis    [ 58 clinical trials,   50 drugs,   (DrugBank: 18 drugs),   17 drug target genes,   96 drug target pathways]
Searched query = "Generalised pustular psoriasis", "Pustular psoriasis", "Herpetic impetigo", "Generalization of acrodermatitis continua", "Generalization of dermatitis continua of the extremities"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 58 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01680159
(ClinicalTrials.gov)		July 201228/8/2012A Clinical Study of Increased Dose of TA-650 in Patients With PsoriasisPlaque Psoriasis;Psoriatic Arthritis;Pustular Psoriasis (Excluding a Localized);Psoriatic ErythrodermaDrug: TA-650Mitsubishi Tanabe Pharma CorporationNULLCompleted16 Years75 YearsAll51Phase 3Japan

56. Behcet disease    [ 68 clinical trials,   87 drugs,   (DrugBank: 31 drugs),   36 drug target genes,   113 drug target pathways]
Searched query = "Behcet disease", "Behçet disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 68 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01532570
(ClinicalTrials.gov)		January 20126/2/2012Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special LesionsTo Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Patients With Behcet's Disease ( BD ) With Special Lesions After the Administration of TA-650Behcet's Disease;Behcet Syndrome;Neuro-Behcet's DiseaseDrug: TA-650Mitsubishi Tanabe Pharma CorporationNULLCompleted16 Years75 YearsAll18Phase 3Japan

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,209 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01580670
(ClinicalTrials.gov)		March 20123/4/2012Clinical Study of TA-650 in Pediatric Patients With Crohn's DiseaseClinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Crohn's DiseasePediatric Crohn's DiseaseDrug: TA-650Mitsubishi Tanabe Pharma CorporationNULLCompleted6 Years17 YearsAll14Phase 3Japan
2NCT00805766
(ClinicalTrials.gov)		December 20089/12/2008Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)Clinical Study to Assess the Efficacy and Safety of Increased Dose of TA-650 in Patients With Crohn's Disease (CD)Crohn's DiseaseDrug: TA-650Mitsubishi Tanabe Pharma CorporationNULLCompleted16 Years75 YearsAll39Phase 3Japan

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,269 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01585155
(ClinicalTrials.gov)		February 201224/4/2012Clinical Study of TA-650 in Pediatric Patients With Ulcerative ColitisClinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Ulcerative Colitis.Pediatric Ulcerative ColitisDrug: TA-650Mitsubishi Tanabe Pharma CorporationNULLCompleted6 Years17 YearsAll21Phase 3Japan
2JPRN-JapicCTI-060298
24/08/2006Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitisClinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitis Ulcerative colitisIntervention name : TA-650 (Infliximab)
Dosage And administration of the intervention : Intravenous drip infusion		Mitsubishi Tanabe Pharma CorporationNULL16BOTHPhase 3NULL

Back to top